Skip to main content
Log in

A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-β-hydroxylase deficiency in Campania region

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A neonatal screening for both 21-hydroxylase and 11-β-hydroxylase deficiencies, responsible for congenital adrenal hyperplasia (CAH), has been conducted in Campania Region, Southern Italy. In 4380 neonates, aged 2–10 days, capillary blood from a heel prick was collected on microfilter paper, and 17-α-hydroxyprogesterone (17OHP) measured by radioimmunoassay (RIA) using a highly specific antibody (Ab A). In addition, in 295 of these samples, both 17OHP and 11-deoxycortisol (S) were measured using an anti-deoxycortisol antibody (Ab B) cross-reacting with 17OHP 100%. All results were compared with plasma 17OHP and S levels in 21 patients with diagnosed 21-hydroxylase deficiency and in 5 healthy volunteers on metyrapone test used for blocking the 11-β-hydroxylase activity. CAH due to 21-hydroxylase deficiency was diagnosed in a female newborn. The assay, based on the antibody reacting with both 17OHP and S, is particularly suitable for wide-scale screening programs enabling the simultaneous detection of two congenital enzyme defects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lombardi G., Oliver C., Lupoli G., Minozzi M., Corticotrophic and melanotrophic function in congenital adrenal hyperplasia. Acta Endocrinol. (Copenh.) 85: 118, 1977.

    CAS  Google Scholar 

  2. Pang S.Y., Wallace M.A., Hofman L., Thuline H.C., Dorche C., Lyon I.C., Dobbins R.H., Kling S., Fujieda K., Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81: 866, 1988.

    PubMed  CAS  Google Scholar 

  3. White C.P., New M.I., Dupont B. Congenital adrenal hyperplasia. N. Engl. J., Med. 316: 1519, 1987.

    Article  CAS  Google Scholar 

  4. Thompson R., Seargeant L., Winter J.S. Screening for congenital adrenal hyperplasia: Distribution of 17-alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens. J. Pediatr. 114: 400, 1989.

    Article  PubMed  CAS  Google Scholar 

  5. Cacciari E., Balsamo A., Cassio A., Piazzi S., Bernardi F., Salardi S., Cicognani A., Pirazzoli P., Zappulla F., Cappelli M., Paolini M. Neonatal screening for congenital adrenal hyperplasia. Arch. Dis. Child. 58: 803, 1983.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Honda M., Nowaczynski W., Guthrie G.P., Nesserli F.H., Tolis G., Kuchel O., Genest J. Response of several adrenal steroids to ACTH stimulation in essential hypertension. J. Clin. Endocrinol. Metab. 44: 264, 1977.

    Article  PubMed  CAS  Google Scholar 

  7. De Simone G., Tommaselli A.P., Rossi R., Valentino R., Lauria R., Scopacasa F., Lombardi G. Partial deficiency of adrenal 11-β-hydroxylase. A possible cause of primary hypertension. Hypertension 7: 204, 1985.

    Article  PubMed  Google Scholar 

  8. Pang S., Hotchkiss J., Drash A.L., Levine L.S., New M.I. Microfilter paper method for 17-α-hydroxy-progesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J., Clin. Endocrinol. Metab. 45: 1003, 1977.

    Article  CAS  Google Scholar 

  9. Solyom J. Blood-spot 17-α-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia. Clin. Endocrinol. (Oxf.) 14: 547, 1981.

    Article  CAS  Google Scholar 

  10. Valentino R., Lombardi G., Tommaselli A.P., Rossi R., Scopacasa F., Fariello C., Di Gennaro C., Minozzi M. Neonatal screening of congenital adrenal hyperplasia due to deficit of 21-hydroxylase and/or 11-β-hydroxylase: use of an anti-11-deoxycortisol antibody. J. Endocrinol Invest 6 (Suppl. 1): 89, 1983.

    Google Scholar 

  11. Newsome H.H., Clements A.S., Borum E.H. The simultaneous assay of Cortisol, corticosterone, 11-deoxycortisol and cortisone in human plasma. J. Clin. Endocrinol. Metab. 34: 473, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Pang S., Pollack M.S., Loo M., Green O., Nussbaum R., Clayton G., Dupont B., New M.I. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 61: 89, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Scrocca A., Valentino R., Sposato G., Tommaselli A.P., Lombardi G. Correzione chirurgica delle anomalie dei genitali nello pseudoermafroditismo femminile da iperplasia surrenale congenita. Riv. Ital. Chir. Plast. 12: 1, 1980.

    Google Scholar 

  14. Abraham G.E., Manlimos F.S., Garza R. Radioimmunoassay of steroids. In: Jaffe B.M., Behrman H.R. (Eds.), Handbook of radioimmunoassay. Academic Press, New York, 1977, p. 590.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valentino, R., Tommaselli, A.P., Rossi, R. et al. A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-β-hydroxylase deficiency in Campania region. J Endocrinol Invest 13, 221–225 (1990). https://doi.org/10.1007/BF03349544

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349544

Key-words

Navigation